Bluebird Bio Stumbles Over Secondary Offering
Bluebird Bio saw its shares dip on Wednesday after the firm announced the pricing of a secondary offering of more than 3 million shares.
All Work
Chris Lange
Why Cellectis Is Winning Big With Its Pfizer Partnership
Cellectis saw its shares make a handy gain early on Wednesday after the firm announced preliminary data from its two Phase 1 studies in conjunction with Pfizer.
Why Apple Is Pumping About $400 Million Into Finisar
Finisar saw its shares soar early on Wednesday after the firm announced that Apple would be investing $390 million.
Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a mixed day for the broad U.S. markets. The Dow and S&P 500 again hit intraday highs, while the Nasdaq lagged. Crude oil gave back all its gains from Monday and then…
6 Stocks Catching Multiple Upgrades and Downgrades
24/7 Wall St. has taken a look at some of the biggest analyst calls on Monday that are driving stocks and we have included some of the biggest analyst highlights.
Why Proteostasis Shares Are Exploding
Proteostasis Therapeutics shares absolutely exploded in Tuesday’s session, more than doubling after the firm reported positive study results.
What Netflix Subscribers Watched the Most in 2017
Netflix has taken a look at itself and its subscribers and profiled what everyone is watching.
Major Oil Short Sellers Run for Cover
The November 30 short interest data have been compared with the previous figures, and short interest for most of the selected big oil stocks decreased.
Short Sellers Can’t Make Up Their Minds on Major Pharma
The November 30 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Short Sellers Hike Bets in Semiconductor Stocks
The November 30 short interest data have been compared with the previous report. Short interest increased in most of these selected semiconductor stocks.
Major Biotechs See Rising Tide in Short Interest
The November 30 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Short Sellers Grow More Selective on Social Media Stocks
The November 30 short interest data have been compared with the previous report. Short interest in these selected social media stocks was mixed for this settlement date.
Bank of America Sees Massive Surge in Short Interest
Bank of America saw one of the biggest shifts in its short interest in the most recent two-week period. It was also one of the most shorted stocks on the New York Stock Exchange.
Short Sellers Back Off Cybersecurity Stocks
The November 30 short interest data have been compared with the previous figures, and short interest in most of these selected cybersecurity stocks decreased.
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a solid day for the broad U.S. markets. This is a good start to the week for Dow, S&P 500 and Nasdaq after each one had a couple rough days last week.…
What Will Apple Do With Shazam?
Apple saw its shares lurch higher on Monday after the iPhone giant announced its newest acquisition -- Shazam, a mobile app that identifies music.
Why Symantec Is Partnering With Oracle
Symantec saw its share make a handy gain to start out the week, after it was announced that the firm’s major cloud security components would now be available on the Oracle Cloud Marketplace.
Gas Prices Ease Near Post-Harvey Low Nationwide
As oil prices fluctuated a fair amount last week, gasoline prices moved lower, with the average price dropping to $2.45 a gallon.
Blueprint Medicines Wins Big in Early-Stage Trial
Blueprint Medicines watched its shares make a solid gain on Monday morning after the firm announced results for its ongoing early-stage trial for advanced systemic mastocytosis.
Costco, Oracle and More Earnings Coming This Week
24/7 Wall St. has put together a preview of Adobe, Costco, Oracle and some of the other top companies reporting their latest results in the coming week.